Evodiamine treatment of H1975 cells for 72 h yielded an IC50 of 5.59 ± 0.88 μM in MTT cell viability assays. In 253J cells, Evodiamine yielded an IC50 of 1.90 ± 0.31 μM after 24 h, with viability assessed by MTT assay. In H1650 cells treated with Evodiamine for 72 h, MTT cell viability assays gave a reported value of 4.53 ± 1.46 μM. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Evodiamine and cell viability in H1975 cells
Cell-based study · H1975 [1]
H1975 cells were treated with Evodiamine for 72 h, and cell viability was measured by MTT assays. The IC50 was 5.59 ± 0.88 μM.
Literature-Reported Treatment Conditions
- Exposure duration
- 72 h
- Vehicle
- dimethyl sulfoxide (DMSO)
- Reported limits
- Not stated in the sentences used: dose, route, control.
Methods and source locations
Compound reported in the paper: Evodiamine
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and method reagents > Materials (S1); Results > Evodiamine can inhibit growth and induce apoptosis of NSCLC cells (S51, S54); Fig. 1 legend (S125)
cell viability was detected by MTT assays: cell viability was detected by MTT assays — Results > Evodiamine can inhibit growth and induce apoptosis of NSCLC cells (S54); Fig. 1 legend (S125)
Evodiamine and cell viability in 253J cells
Cell-based study · 253J [2]
253J cells were treated with Evodiamine for 24 h, and cell viability was assessed by MTT assay. The IC50 was 1.90 ± 0.31 μM.
Literature-Reported Treatment Conditions
- Exposure duration
- 24 h
- Reported limits
- Not stated in the sentences used: dose, route, vehicle.
Methods and source locations
Compound reported in the paper: Evodiamine
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Evodiamine Induces Apoptosis in Human Bladder Cancer Cells (S2, S4); Figure 1. legend (S106)
Cell viability was assessed by MTT assay: Cell viability was assessed by MTT assay; comparator: control — Results > Evodiamine Induces Apoptosis in Human Bladder Cancer Cells (S4); Figure 1. legend (S106)
Evodiamine and cell viability in H1650 cells
Cell-based study · H1650 [1]
H1650 cells were treated with Evodiamine for 72 h, and cell viability was measured by MTT assays. The reported value was 4.53 ± 1.46 μM.
Literature-Reported Treatment Conditions
- Exposure duration
- 72 h
- Vehicle
- dimethyl sulfoxide (DMSO)
- Reported limits
- Not stated in the sentences used: dose, route, control.
Methods and source locations
Compound reported in the paper: Evodiamine
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and method reagents > Materials (S1); Results > Evodiamine can inhibit growth and induce apoptosis of NSCLC cells (S51, S54); Fig. 1 legend (S125)
cell viability was detected by MTT assays: cell viability was detected by MTT assays — Results > Evodiamine can inhibit growth and induce apoptosis of NSCLC cells (S54); Fig. 1 legend (S125)